Drug‐Coated Balloon Versus Drug‐Eluting Stent for Femoropopliteal Lesions: A 3‐Year Propensity Score‐Matched Analysis
Catheterization and Cardiovascular Interventions · 16.07.2026
DOI: 10.1002/ccd.70750 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 16.07.2026. Verfasst von Osamu Iida und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Division, Osaka Keisatsu Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Cardiovascular Agents, Coated Materials, Biocompatible, Drug-Eluting Stents. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Objective
While drug‐eluting treatment is a first‐line therapy for femoropopliteal (FP) lesions, long‐term comparative data between drug‐eluting stents (DES) and drug‐coated balloons (DCB) in real‐world practice are scarce. We aimed to compare the 3‐year outcomes of DES versus DCB for symptomatic FP disease.
Methods
We conducted a retrospective analysis of the CILANTRO study, a multicenter registry combining data from the CAPSICUM, POPCORN, and POPCORN Type R studies. Patients treated with either DES or DCB for symptomatic FP lesions were included. To minimize selection bias, we performed 1:1 propensity score matching. The primary outcome was clinically driven target lesion revascularization (TLR), while secondary outcomes included restenosis.
Results
A total of 2651 patients treated with DCB and 972 with DES were identified. Propensity score matching extracted 912 pairs with well‐balanced baseline characteristics. The median follow‐up period was 31.6 months. The 3‐year rate of TLR was not significantly different between the DCB and DES groups (23.3% vs. 18.8%; hazard ratio, 1.19 [95% confidence interval, 0.93–1.53]; p = 0.16). Interaction analysis revealed that a more marked increased risk of TLR in the DCB group in patients with semi‐compliant balloon use or without non‐compliant balloon use ( p = 0.017 and 0.018). The 3‐year rate of restenosis was significantly higher in the DCB group than in the DES group (38.1% vs. 26.3%; hazard ratio, 1.77 [1.43–2.19]; p < 0.001).
Conclusions
In this propensity score‐matched analysis, the 3‐year rate of TLR was not significantly different between DCB and DES, although DES demonstrated lower restenosis rate. Nevertheless, DCB remains a clinically viable option, and our sub‐analysis suggests that balloon selection for pre‐dilatation may influence its efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Division, Osaka Keisatsu Hospital, Osaka, Japan.
- Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
- Department of Laboratory Medicine, The University of Osaka Graduate School of Medicine, Suita, Japan.
- Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
- Department of Cardiology, Morinomiya Hospital, Osaka, Japan.
- Department of Cardiology, Kishiwada Tokushukai Hospital, Kishiwada, Japan.
ORCID-Profile: Yoshimitsu Soga, Yusuke Tomoi, Amane Kozuki, Akiko Tanaka
Zitieren
APA
Iida, O., Takahara, M., Soga, Y., Tomoi, Y., Kawasaki, D., Fujihara, M., Kozuki, A., Tanaka, A., Yamauchi, Y., Tobita, K., Yamaoka, T., Ichihashi, S., Sakata, Y., & CILANTRO investigators (2026). Drug‐Coated Balloon Versus Drug‐Eluting Stent for Femoropopliteal Lesions: A 3‐Year Propensity Score‐Matched Analysis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70750
Vancouver
Iida O, Takahara M, Soga Y, Tomoi Y, Kawasaki D, Fujihara M, et al. Drug‐Coated Balloon Versus Drug‐Eluting Stent for Femoropopliteal Lesions: A 3‐Year Propensity Score‐Matched Analysis. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70750
BibTeX
@article{Iida2026,
author = {Iida, Osamu and Takahara, Mitsuyoshi and Soga, Yoshimitsu and Tomoi, Yusuke and Kawasaki, Daizo and Fujihara, Masahiko and Kozuki, Amane and Tanaka, Akiko and Yamauchi, Yasutaka and Tobita, Kazuki and Yamaoka, Terutoshi and Ichihashi, Shigeo and Sakata, Yasushi and CILANTRO investigators, CILANTRO investigators},
title = {Drug‐Coated Balloon Versus Drug‐Eluting Stent for Femoropopliteal Lesions: A 3‐Year Propensity Score‐Matched Analysis},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70750}
}
EUVIMED